Botox Maker Offers Up To $375M For Fellow Skin Care Co.

Law360, New York (November 16, 2012, 3:41 PM EST) -- Allergan Inc., the maker of the popular Botox injection, will scoop up private-equity-backed SkinMedica Inc. to bolster its topical skin-care product offerings in a deal worth up to $375 million, the companies said Friday.

Under the deal's terms, Allergan will pay $350 million up front and make a follow-up payment of $25 million if SkinMedica's products hit certain sales targets. Through the transaction, Allergan would lift SkinMedica ownership from nearly a dozen investment firms including Apax Partners LLP and BlueCrest Capital Management LLP.

In the sale,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.